Letter by Lowenthal et al regarding article, "bNP levels predict outcome in pediatric heart failure patients: Post hoc analysis of the pediatric carvedilol trial"

Circulation: Heart Failure

Volumn 3, Issue 6, 2010, Pages

  Lowenthal, Alexander ^a   Shah, Amee ^b   Bernstein, Harold S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

CARDIAC PATIENT; DISEASE ASSOCIATION; HEART FAILURE; HEART RIGHT VENTRICLE; HUMAN; LETTER; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ADRENERGIC BETA-ANTAGONISTS; CARBAZOLES; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PROPANOLAMINES;

EID: 78650100199     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.110.958470     Document Type: Letter

References (3)

1. Auerbach SR, Richmond ME, Lamour JM, Blume ED, Addonizio LJ, Shaddy RE, Mahony L, Pahl E, Hsu DT. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial. Circ Heart Fail. 2010;3:606-611.
2. Shah A, Feraco AM, Harmon C, Tacy T, Fineman JR, Bernstein HS. Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology. Am J Cardiol. 2009;104: 1280-1284.
3. Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, Ross RD, Pahl E, Blume ED, Dodd DA, Rosenthal DN, Burr J, LaSalle B, Holubkov R, Lukas MA, Tani LY. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298: 1171-1179.